Ordinary people may often hear that exports of steel, photovoltaic and other products in China often cause damage to the interests of exporting enterprises due to the trade protection measures imposed by importing countries. Few people actually know that in fact, China's pharmaceutical products have also suffered a great deal of unfairness in recent years Treatment.
At the conference on the situation of China's pharmaceutical foreign trade held on February 6, the data released by China Chamber of Commerce for Import and Export of Medicines and Health Products (hereinafter referred to as 'Medicare Chamber of Commerce') showed that in 2017, 15 pharmaceutical trade friction cases were exported to China.
Meng Dongping, vice president of the Medicare Chamber of Commerce on the "Daily Economic News" told reporters that trade friction is often encountered by enterprises going abroad in the case of international trade, when the product's market share, competitiveness will increase, it will Squeeze opponents of space.With the entire pharmaceutical industry to deepen the degree of access to international markets, the situation facing the Chinese pharmaceutical companies besieging more and more obvious, companies in the process of going out need to develop skills and ability to deal with trade friction.
Advantages of pharmaceutical raw materials often encounter trade friction
In recent years, the trade friction experienced by the pharmaceutical industry in our country shows a clear upward trend.Chinese Medicines and Health Products Import and Export Chamber of Commerce data show that since 2010, nine countries have launched or are in the process of China's pharmaceutical products launched a total of 73 trade friction incident.
From a country perspective, India is the country that has launched the most anti-dumping allegations against Chinese pharmaceutical products, and in 2017 alone, India launched five anti-dumping investigations and one anti-circumvention investigation.
In the United States, the United States launched four "337 investigations" of intellectual property infringement and one antitrust lawsuit in 2017. In addition, in 2017, the EU launched two anti-dumping investigations on Chinese pharmaceutical products and Ukraine also initiated 1 Anti-dumping investigations.
Zhang Bei Bei, deputy director of the Legal Protection Department of the Medicare Chamber of Commerce, said that in addition to the advantages of raw pharmaceutical products, medical products that have suffered from trade friction in China have also had higher technological added value in recent years such as patient monitors and gemcitabine (an anti-cancer proprietary drug) Easily be the new target of investigating cases.
'This can be described as' growing troubles. '' Zhang Beibei told the Daily Economic News reporters that the dominant industries in China's pharmaceutical industry may often be more susceptible to questioning. The industry is getting stronger, so the face of such a situation more and more.
From the products involved point of view, some new features began to appear.Zhang Beibei said that since the API, pharmaceutical exports in China accounted for a large proportion, currently accounts for about 60%, so raw material medicine trade friction is more, but from For the moment, some products with higher added value have also encountered anti-dumping investigations.
Zhang Beibei pointed out that the friction on APIs are some of the old cases that are undergoing reexamination and other links, and many of the newly issued ones in recent years are products of higher added value, which is obviously manifested in the United States. The U.S. conducted a total of more than a dozen "337 Investigations" on pharmaceutical products in China, up from 4 in 2017.
Zhang Beibei said that this also shows that the enhancement of the competitiveness of Chinese enterprises is viewed by the United States, and the United States regards some Chinese enterprises as rivals and finds that the intellectual property infringement on its core interests by Chinese enterprises.
The reporter noted that the U.S. 337 investigation involved gemcitabine, a birth simulator, ventilator, stevioside, etc. Zhang Beibei said that these products already have a high market share at home or abroad, some with independent intellectual property rights and a number of international Patents, product technology content and quality level of the world's leading level.
There are well-established mechanisms to deal with trade frictions
Meng Dongping said that because of the characteristics of some captured trade frictions, many are the anti-dumping investigations launched by trade competitors, which is a means of suppressing the industry in our country.
Zhangbei Bei said that enterprises were initiated in foreign countries to investigate anti-dumping cases. Enterprises must assess whether they can endure the final judgment of tariffs and re-evaluate the market in all aspects of the country. The pace of competition in the market will be disrupted, Production and operation and layout impact.
Zhang Beibei pointed out: In some countries, the enterprises provoking trade frictions are not thinking at all about winning the case, but more likely to win their own time and disrupt themselves through the steps of entering Chinese enterprises into the international market. Advantage.
A pharmaceutical company told the "Daily Economic News" reporter said India had its anti-dumping investigation of its metronidazole products, but when the company is ready to deal with the relevant materials and documents to prepare, and the other party has been withdrawn from prosecution.
Meng Dongping said that enterprises in the face of trade friction, but also without too much worry and pressure, trade friction is only a means of international competition only with the internationalization of China's pharmaceutical industry, the trend of development, more and more enterprises are upgrading The concept of internationalization, the awareness and ability to participate in the international division of labor are all on the rise, and the capacity to deal with trade frictions is rising.
To deal with the trade friction, Zhang Beibei also pointed out that at present there are perfect four-body linkage mechanism, with government departments, trade organizations, enterprises themselves, professional lawyers team efforts to solve four areas, the operation is very mature and can help enterprises to deal with In particular, medical insurance providers can give play to their professional advantages and can make ex ante adjustments to their trade conflicts through consultations with the industry on the basis of trade frictions, carry out equal consultations, exchange and mutual understanding, reach a settlement agreement and resolve disputes.
Click on the picture below to register the show!
